SCHEMBL14601019

SCHEMBL14601019

Cc1cc(-c2ccccc2F)cc([N+](=O)[O-])c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.52
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
ACHE P22303 3/20 0.46
CYP19A1 P11511 1/20 0.41
AKR1C3 P42330 2/20 0.40
AKR1C2 P52895 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
CCKBR P32239 1/20 0.40
GABRA3 P34903 1/20 0.40
OPRK1 P41145 1/20 0.40
MC3R P41968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16342390 0.83 TSHR (0.50) TSHRACHECYP19A1AKR1C3AKR1C2
SCHEMBL30659234 0.79 PTPRC (0.46) NPC1RAB9AACHEAKR1C3AKR1C2
SCHEMBL26355870 0.79 TSHR (0.49) TSHRACHECYP19A1AKR1C3AKR1C2
SCHEMBL6799377 0.79 NPC1 (0.68) TSHRNPC1RAB9AAKR1C3AKR1C2
SCHEMBL12717419 0.78 TSHR (0.61) TSHRNPC1RAB9AACHECYP19A1
SCHEMBL4486234 0.78 MEN1 (0.50) NPC1RAB9AAKR1C3AKR1C2MEN1
SCHEMBL18610494 0.77 PTPRF (0.53) RAB9AMEN1KMT2ALMNAMAPT
SCHEMBL16342549 0.76 SMN1; SMN2 (0.55) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL18585590 0.76 KMT2A (0.51) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL11691049 0.76 ALDH1A1 (0.51) NPC1RAB9AACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007032936-A2 AZAFUSED CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-03-22 WO disclosed